Email this article Xerostomia: a brief look of the problem
- Authors: Podvyaznikov SO1
-
Affiliations:
- ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ, Москва
- Issue: Vol 15, No 1 (2013)
- Pages: 46
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26885
- ID: 26885
Cite item
Full Text
Abstract
Xerostomia is iatrogenically and non-iatrogenically manifested in patients for a number of reasons and detectable in 12% of the world’s population and its prevalence in the elderly amounts to as much as 25%. Oncologically, xerostomia remains a problem in patients receiving radiotherapy for malignant tumors of the upper respiratory and digestive tracts. The basis for hyposialia prophylaxis is oral hygiene (that is to prevent and treat caries and fungal superinfection). In more complex cases of significant xerostomia, saliva substitutes are used, which give patients instant functional relief.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
S O Podvyaznikov
ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ, Москвад-р мед. наук, проф. каф. онкологии
References
- Guggenheimer J et al. J Am Dent Assos 2003; 13: 61–9.
- Altkinson J.C. et al. Dent Clin North AM 2005; 49 (2): 309–26.
- Mariette X. Rev Med Intern 2004; 25: 287–93.
- Sciubba J.J. et al. Lancet Oncol 2006; 7 (2): 175–83.
- Dirix P et al. Cancer 2006; 107 (1): 2525–34.
- Gentric-Tilly A et al. Ann Med Intern (Paris) 2002; 153: 378–82.
- Novaresh M et al. JADA 2008; 139: 355–405.
- Mariette X. Rev Med Intern 2004; 25: 287–93.
Supplementary files
